 Mae raglun ymchwil ac arloesu fwyaf erioed yr yw'n deb euwrepiau, horizon i gain, i gain, a'r agor ac yn cynnig cyfleoedd i sefydliadau Cymru fod ar flaen y gard yn y byd ymchwil ac arloesu. Mae Crinodeb ystadegol diweddaraf y Cymusio'n Euwrepiau, sy'n rhoi sefydlu ar 31 o fau 2017. Yn dangos bod sefydliadau Cymru wedi llwyddo i sicrhau 76 miliwn euro o galed erbyn hyn. Dyma rai o rychaf fwyafiau. Mae cant 62 o sefydliadau ac unigolion o Gymru wedi cymryd rhan yn y horizon i gain i gain. Mae mwy na 1.600 o enghraifftiau o gydweithredu yr yngladol gan sefydliadau o Gymru yn horizon i gain i gain. Mae'r sector adesg ywch yn dal i fyneud yn dda ac wedi sicrhau pedwar 19 miliwn euro hyd yma. Mae'r sector private wedi denu bron i 1.600 miliwn euro ac mae nim yn un enghraifft o lwyddiant. Nim Biotech is a Life Sciences Organisation based in Abbottolary in Wales. Nim's prime focus is antimicrobial development and we're very proud to be about to be moving into our first clinical trial for a first in class anti-infective. Nim is the work programme leader of the first work programme which is quite specifically focused on the biorefining of active compounds and this is on the basis of Nim's extensive experience in extraction of high value chemicals from plants and plant waste and as well as our extensive experience in the development of antimicrobial compounds. We've been part of collaborative projects for many years and the reason why we do that and the reason why quite specifically collaborative projects across the European Union are so important to us is for us to develop relationships with the leading scientists and leading SMEs in our area that allow us to develop our resources and develop our staff and develop our capabilities. We see this as an opportunity for our organisation to have the right skills and the right partners to bring products to the market. Access to funds through collaborative projects has always been a way of us to be able to develop expertise and the fungus chain project in particular has allowed us to actually hire extra expertise into the organisation that we would not have been able to do prior to the project. It's also allowed us to expand our technical resources and hence beyond this project we now have skills and infrastructure that we can use for other things in the future. At the end of the project we hope to have achieved three outcomes. The first one is to have developed new extraction technologies which is what we've been doing for so many years and what we hope to protect with patents to have discovered new antimicrobials that we can put into our development pipeline for potential future drugs. But most importantly I think the outcome of this project needs to be the fact that we're aiming to use a waste product that's currently being used as a fertilizer that can add significant value to an entire industry.